IPOs and Secondaries

IPOs and Secondaries Articles

Camping World Holdings entered the market on a positive note, with shares going out at the mid-point in their expected price range of $21 to $23.
Shares of Acacia Communications have pulled back on news of a secondary offering of more than 4 million shares.
Everspin Technologies expects to price its 5 million shares at $8 apiece for an initial public offering is valued up to $46 million.
If Saudi Aramco can get its ducks in a row, we may see a 2018 initial public offering that would create the most valuable public company in the world.
Inventory Global, Inc. (NASDAQ: INVT) saw its shares slide on Thursday after the company announced that it would be having a secondary offering. The company intends to price 6 million shares at $1...
Shares of Idera Pharmaceuticals sank on Thursday after the company announced that it intends to have a secondary offering.
GDS Holdings has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Coupa Software entered the market sharply higher than anyone had really expected.
The reaction was somewhat mixed when Advanced Disposal Services entered the market on Thursday.
Shares of Immunomedics dropped sharply on Wednesday after the company announced the pricing of its secondary offering.
Coupa Software expects to price more than 7 million shares in the range of $16 to $18 per share for an initial public offering valued up to around $153 million.
Jaguar Animal Health Inc. (NASDAQ: JAGX) filed a Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering. The expected price of the 4.32 million shares is...
Acushnet Holdings has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). There were no pricing details listed in the filing but...
Mammoth Energy Services intends to price more than 7 million shares in the range of $15 to $18 per share for an initial public offering valued up to nearly $165 million.
Ra Pharmaceuticals has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).